2 assets in Extrinsic Cardiomyopathy

Therapeutic assets addressing Extrinsic Cardiomyopathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
High Dose Lx2006 Extrinsic Cardiomyopathy	Lexeo Therapeutics	P1/2	CCC (48)
Low Dose Lx2006 Extrinsic Cardiomyopathy	Lexeo Therapeutics	P1/2	CCC (48)